Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. May 27, 2025; 17(5): 101323
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.101323
Table 1 Baseline and surgical characteristics according to morbidity of all 111 patients in the study, n (%)
CharacteristicAll patients (n = 111)Overall postoperative infection
Intra-abdominal infection
No (n = 92)
Yes (n = 19)
P value
No (n = 103)
Yes (n = 8)
P value
Age (years), mean ± SD60.7 ± 10.360.7 ± 10.560.8 ± 9.60.95760.7 ± 10.360.0 ± 11.90.849
Sex
Men29 (26.1)24 (82.8)5 (17.2)0.98426 (89.7)3 (10.3)-
Women82 (73.9)68 (82.9)14 (17.1)-77 (93.9)5 (6.1)0.447
ASA score, mean ± SD2.2 ± 0.62.2 ± 0.62.4 ± 0.60.2622.2 ± 0.62.4 ± 0.70.473
Neoadjuvant chemotherapy
No51 (45.0)45 (88.2)6 (11.8)0.16748 (94.1)3 (5.9)0.619
Yes60 (54.1)47 (78.3)13 (21.7)-55 (91.7)5 (8.3)-
Immunonutrition
No62 (55.9)53 (85.5)9 (14.5)0.41359 (95.2)3 (4.8)0.278
Yes49 (44.1)39 (79.6)10 (20.4)-44 (89.8)5 (10.2)-
Carcinomatosis origin
Ovarian55 (49.5)48 (87.3)7 (12.7)-54 (98.2)1 (1.8)-
Colorectal34 (30.6)24 (70.6)10 (29.4)-28 (82.4)6 (17.7)-
Pseudomyxoma13 (11.7)13 (100.0)0 (0.0)-13 (100.0)0 (0.0)-
Gastric2 (1.8)1 (50.0)1 (50.0)12 (100.0)0 (0.0)1
Endometrial2 (1.8)2 (100.0)0 (0.0)-2 (100.0)0 (0.0)-
Mesothelioma1 (0.9)1 (100.0)0 (0.0)-1 (100.0)0 (0.0)-
Primary1 (0.9)1 (100.0)0 (0.0)-1 (100.0)0 (0.0)-
Neuroendocrinal1 (0.9)1 (100.0)0 (0.0)-1 (100.0)0 (0.0)-
Others2 (1.8)1 (50.0)1 (50.0)-1 (50.0)1 (50.0)-
PCI, median ± SD10.4 ± 6.510.5 ± 6.79.5 ± 5.40.52010.4 ± 6.610.0 ± 5.30.874
Complete cytoreduction97 (87.4)78 (80.4)19 (19.6)0.06989 (91.8)8 (8.3)0.265
Number of visceral resections, mean ± SD1.6 ± 1.21.5 ± 1.22.0 ± 1.20.1611.6 ± 1.22.0 ± 1.10.324
Number of digestive anastomoses, mean ± SD0.6 ± 0.60.5 ± 0.71.0 ± 0.70.0530.6 ± 0.61.2 ± 0.50.049
HIPEC
No23 (20.7)17 (73.9)6 (26.1)0.20020 (87.0)3 (13.0)0.224
Yes88 (79.3)75 (85.2)13 (14.8)-83 (94.3)5 (5.7)-
In hospital stay, median ± SD15.6 ± 7.214.9 ± 7.119.0 ± 6.60.02215.1 ± 7.022.3 ± 6.30.006
Reintervention11 (9.9)5 (45.5)6 (54.5)0.0007 (63.6)4 (36.4)0.000
Mortality2 (1.8)1 (50.0)1 (50.0)0.2132 (100.0)0 (0.0)0.691
Table 2 Daily levels of C-reactive protein and neutrophil-to-lymphocyte ratio in all patients according to the presence or absence of overall postoperative infection and in the presence or absence of intra-abdominal infection
CharacteristicAll patients (n = 111)Overall postoperative infection
Intra-abdominal infection
No (n = 92)
Yes (n = 19)
P value
No (n = 103)
Yes (n = 8)
P value
Day 1
CRP (mg/L)79.5 (58.0-102.0)77.0 (58.0-101.0)91.0 (51.0-119.0)0.39077.5 (58.0-101.3)89.5 (73.0-165.5)0.114
NLR (mg/L)10.4 (6.2-16.2)10.2 (6.1-15.8)10.4 (6.6-23.4)0.6829.9 (6.2-15.2)15.9 (4.0-28.0)0.228
Day 2
CRP (mg/L)91.5 (65.3-147.0)87.0 (60.0-127.0)145.0 (81.0-187.0)0.01388.1 (62.3-143.5)143.0 (76.5-195.5)0.195
NLR (mg/L)10.4 (7.2-14.5)10.4 (7.1-14.3)9.6 (7.2-15.6)0.37710.3 (7.2-14.3)13.3 (5.9-17.7)0.707
Day 3
CRP (mg/L)75.0 (47.0-140.0)70.4 (44.5-120.5)153.5 (100.3-240.3)0.00173.0 (47.0-136.0)119.0 (38.0-167.8)0.442
NLR (mg/L)10.0 (7.0-12.2)10.5 (7.1-12.1)8.4 (6.1-17.1)0.67410.0 (7.0-12.1)9.9 (4.9-33.4)0.783
Day 4
CRP (mg/L)99.5 (48.5-155.3)80.5 (46.5-128.0)151.5 (90.8-204.6)0.04796.5 (49.3-156.8)123.5 (40.1-163.5)0.918
NLR (mg/L)8.4 (6.2-11.1)8.1 (6.0-10.4)9.3 (6.7-18.5)0.1208.2 (6.2-10.6)8.73 (6.4-24.2)0.294
Table 3 Daily area under the receiver operating characteristic curve of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with overall postoperative infection and with intra-abdominal infection
Characteristic
AUC for OPI (95%CI)
P value
AUC for IAI (95%CI)
P value
Day 1
CRP (mg/L)0.6 (0.4-0.7)0.4530.6 (0.5-0.8)0.201
NLR (mg/L)0.5 (0.4-0.7)0.7160.6 (0.3-0.8)0.448
Day 2
CRP (mg/L)0.7 (0.5-0.8)0.0190.7 (0.5-0.9)0.129
NLR (mg/L)0.5 (0.4-0.7)0.9460.6 (0.3-0.8)0.557
Day 3
CRP (mg/L)0.7 (0.6-0.9)0.0050.6 (0.3-0.8)0.550
NLR (mg/L)0.5 (0.3-0.6)0.6740.5 (0.3-0.8)0.783
Day 4
CRP (mg/L)0.7 (0.5-0.9)0.0380.5 (0.3-0.8)0.831
NLR (mg/L)0.6 (0.5-0.8)0.1200.6 (0.4-0.9)0.294
Table 4 Overall postoperative infection: Daily levels of C-reactive protein depending on immunonutrition intake
CharacteristicImmunonutrition
No (n = 62)
Yes (n = 49)
P value
CRP day 1
Overall postoperative infection60.0 (39.0-121.0)96.4 (82.3-126.0)0.282
No overall postoperative infection77.0 (54.5-95.0)80.0 (63.0-106.7)0.346
CRP day 2
Overall postoperative infection88.0 (61.5-204.0)163.0 (117.0-186.3)0.535
No overall postoperative infection84.0 (52.8-109.0)103.0 (76.7-158.8)0.005
CRP day 3
Overall postoperative infection165.0 (72.5-268.0)125.0 (88.0-167.5)0.313
No overall postoperative infection64.0 (40.5-96.5)102.0 (65.3-143.8)0.008
CRP day 4
Overall postoperative infection154.5 (45.3-187.0)146.0 (108.3-205.7)0.811
No overall postoperative infection65.3 (36.5-122.3)97.0 (62.0-130.0)0.243
Table 5 Intra-abdominal infection: Daily levels of C-reactive protein depending on immunonutrition intake
CharacteristicImmunonutrition
No (n = 62)
Yes (n = 49)
P value
CRP day 1
Intra-abdominal infection113.086.0 (61.0-138.5)0.487
No intra-abdominal infection67.0 (50.0–95.0)81.0 (65.0-113.0)0.112
CRP day 2
Intra-abdominal infection199.0120.0 (78.5-175.5)0.510
No intra-abdominal infection84.0 (53.5-111.0)118.0 (77.0-170.0)0.002
CRP day 3
Intra-abdominal infection114.0124.0 (41.5-167.5)0.642
No intra-abdominal infection67.0 (41.0-114.0)114.4 (65.0-172.0)0.047
CRP day 4
Intra-abdominal infection48.0142.0 (60.8-177.0)0.377
No intra-abdominal infection76.0 (38.0-156.0)102.0 (65.0-172.0)0.278